ESMO Congress Copenhagen 2016
Chair: R. Valdagni, IT Co-Chair: A. Horwich, UK
| Title symposium | Active Surveillance for low risk prostate cancer. Session proposed by ESO |
| Chair | Riccardo Valdagni, Milan, IT |
| Co-Chair | Alan Horwich, Sutton, UK |
| Title presentation 1 | Why do we need Active Surveillance? The problem of overdiagnosis, indolent cancer and overtreatment |
| Speaker 1 | Monique Roobol, Rotterdam, NL |
| Lecture time 1 | 20' |
| Title presentation 2 | What do we mean by Active Surveillance? Definition,criteria far inclusion and management, overview of protocols open far recruitment |
| Speaker 2 | Frank-Jan H. Drost, Rotterdam, NL |
| Lecture time 2 | 20' |
| Title presentation 3 | What do we need to improve the selection and management? Genetic profiling and serum markers |
| Speaker 3 | Anders Bjartell, Malmö, SE |
| Lecture time 3 | 10' |
| Title presentation 4 | What do we need to improve the selection and management? MRI and targeted biopsy |
| Speaker 4 | Caroline Moore, London, UK |
| Lecture time 4 | 10' |
| Title presentation 5 | Living with an untreated cancer. The quality of life of men on Active Surveillance |
| Speaker 5 | Lara Bellardita, Milan, IT |
| Lecture time 5 | 10' |
| Title presentation 6 | Discussion |
| Speaker 6 | All the speakers |
| Lecture time 6 | 20' |
Faculty
Lara Bellardita
Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Lara.Bellardita@istitutotumori.mi.it
Anders Bjartell
Department of Urology,Skfme University Hospital Malmo, Malmo, SE; Department of Clinical Sciences Malmo, Division of Urological Cancers, Lund University, Lund, SE
anders.bjartell@med.lu.se
Frank-Jan H. Drost
Dept. of Radiology and Urology, Erasmus University Medicai Center, Rotterdam, NL
f.drost@erasmusmc.nl
Caroline Moore
Dept. of Surgical and lnterventional Science, University College, London, UK
caroline.moore@ucl.ac.uk
Alan Horwich
The Royal Marsden Hospital, lnstitute of Cancer Research, Sutton, UK
alanhorwich@aol.com
Monique Roobol
Dept. of Urology/Epidemiology, Erasmus University Medicai Center, Rotterdam, NL
m.roobol@erasmusmc.nl
Riccardo Valdagni
ESO Prostate Cancer Programme Coordinator; Prostate Cancer Programme and Division of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
riccardo.valdagni@istitutotumori.mi.it